Sources of Cancer Neoantigens beyond Single-Nucleotide Variants

The success of checkpoint blockade therapy against cancer has unequivocally shown that cancer cells can be effectively recognized by the immune system and eliminated. However, the identity of the cancer antigens that elicit protective immunity remains to be fully explored. Over the last decade, most...

Descripción completa

Detalles Bibliográficos
Autores principales: Capietto, Aude-Hélène, Hoshyar, Reyhane, Delamarre, Lélia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455963/
https://www.ncbi.nlm.nih.gov/pubmed/36077528
http://dx.doi.org/10.3390/ijms231710131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455963/
https://www.ncbi.nlm.nih.gov/pubmed/36077528
http://dx.doi.org/10.3390/ijms231710131

Ejemplares similares